Cargando…

Reliability and longevity of implantable defibrillators

PURPOSE: We hypothesized that data in manufacturers’ product performance reports (PPRs) can provide clinically valuable ICD and cardiac resynchronization defibrillator (CRT-D) reliability and longevity information. METHODS: Data were obtained from 2019 PPRs. Kaplan-Meier (K-M) probabilities of freed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hauser, Robert G., Casey, Susan A., Gitter, Christopher B., Tang, Chuen Y., Abdelhadi, Raed H., Gornick, Charles C., Stanberry, Larissa, Sengupta, Jay D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645539/ https://www.ncbi.nlm.nih.gov/pubmed/33387130 http://dx.doi.org/10.1007/s10840-020-00920-w

Ejemplares similares

High shocking and pacing impedances due to defibrillation lead calcification
por: Hauser, Robert G., et al.
Publicado: (2019)

Leadless pacemaker perforations: Clinical consequences and related device and user problems
por: Hauser, Robert G., et al.
Publicado: (2022)

Interventional electrophysiology at a crossroads
por: Hauser, Robert G., et al.
Publicado: (2022)

Failure of a novel silicone–polyurethane copolymer (Optim™) to prevent implantable cardioverter-defibrillator lead insulation abrasions
por: Hauser, Robert G., et al.
Publicado: (2013)

Deaths and cardiovascular injuries due to device-assisted implantable cardioverter–defibrillator and pacemaker lead extraction
por: Hauser, Robert G., et al.
Publicado: (2010)

Transvenous Implantable Cardioverter-Defibrillator Lead Reliability: Implications for Postmarket Surveillance
por: Kramer, Daniel B, et al.
Publicado: (2015)

Outcomes following persistent atrial fibrillation ablation using localized sources identified with Ripple map
por: Melby, Daniel P., et al.
Publicado: (2019)

Longevity of implantable cardioverter defibrillators: a comparison among manufacturers and over time
por: von Gunten, Simon, et al.
Publicado: (2016)

Ripple Frequency Determined via a Novel Algorithm Is Associated With Atrial Fibrillation Termination and Freedom From Atrial Fibrillation
por: Melby, Daniel P., et al.
Publicado: (2022)

The economic impact of battery longevity in implantable cardioverter-defibrillators for cardiac resynchronization therapy: the hospital and healthcare system perspectives
por: Landolina, Maurizio, et al.
Publicado: (2017)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
por: Begisbayev, Temirkhan, et al.
Publicado: (2022)

Substernal implantation of a subcutaneous implantable cardioverter-defibrillator in a patient with preexisting Hemodialysis Reliable Outflow graft
por: Boyle, Thomas A., et al.
Publicado: (2016)

Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator
por: Uslu, Abdulkadir, et al.
Publicado: (2018)

Azygos Vein Lead Implantation For High Defibrillation Thresholds In Implantable Cardioverter Defibrillator Placement
por: Kommuri, Naga VA, et al.
Publicado: (2010)

Induced atrial fibrillation during defibrillation test on implantation of subcutaneous implantable cardioverter defibrillator
por: Kim, Ki-Hun, et al.
Publicado: (2020)

Implantation of a subcutaneous implantable cardioverter-defibrillator in a patient with epicardial defibrillation patches
por: Yoshizawa, Reisuke, et al.
Publicado: (2021)

Defibrillation Testing of the Implantable Cardioverter Defibrillator: When, How, and by Whom?
por: Pires, Luis A
Publicado: (2007)

Predictors of Elevated Defibrillation Threshold with the Subcutaneous Implantable Cardioverter-defibrillator
por: Do, Khuyen, et al.
Publicado: (2017)

Home monitoring of implantable cardioverter-defibrillators: interpretation reliability of the second-generation “IEGM Online” system
por: Nägele, Herbert, et al.
Publicado: (2015)

An implantable defibrillator and what else?
por: Mont, Lluís, et al.
Publicado: (2009)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

Atrial pacing–induced oversensing in subcutaneous implantable cardioverter-defibrillator
por: Wharmby, Amy, et al.
Publicado: (2023)

Intraoperative defibrillation threshold testing and postoperative long-term efficacy of cardioverter-defibrillator implantation
por: GAN, TIANYI, et al.
Publicado: (2013)

Longevity of implantable cardioverter-defibrillators for cardiac resynchronization therapy in current clinical practice: an analysis according to influencing factors, device generation, and manufacturer
por: Landolina, Maurizio, et al.
Publicado: (2015)

The extravascular implantable cardioverter-defibrillator: characterization of anatomical parameters impacting substernal implantation and defibrillation efficacy
por: Molnár, Levente, et al.
Publicado: (2021)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Subcutaneous implantable defibrillator in dextrocardia secondary to Lobectomy
por: Monkhouse, Christopher, et al.
Publicado: (2018)

Higher defibrillation threshold in methamphetamine cardiomyopathy patients with implantable cardioverter-defibrillator
por: Malhotra, Rakesh, et al.
Publicado: (2017)

Intraoperative Defibrillation Testing of Subcutaneous Implantable Cardioverter‐Defibrillator Systems—A Simple Issue?
por: Frommeyer, Gerrit, et al.
Publicado: (2016)

Subcutaneous Implantable Cardioverter Defibrillators Implantation Without Defibrillation Threshold Testing: A Single Center Experience
por: Al-Ghamdi, Bandar, et al.
Publicado: (2017)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Defibrillation testing during implantation of the subcutaneous implantable cardioverter-defibrillator: a necessary standard or becoming redundant?
por: van der Stuijt, W., et al.
Publicado: (2020)

The extravascular implantable cardioverter‐defibrillator: The pivotal study plan
por: Crozier, Ian, et al.
Publicado: (2021)

Repeat inappropriate defibrillator discharges following defibrillator implantation. What is the mechanism and treatment?
por: Docekal, Jeremy W., et al.
Publicado: (2016)

Intrapericardial Implantation of an Implantable Cardioverter-Defibrillator in a Child
por: Seong, Yong Won, et al.
Publicado: (2011)

A sustained ventricular tachycardia overlooked by subcutaneous implantable cardioverter-defibrillator but recognized by co-implanted transvenous implantable cardioverter defibrillator
por: Goto, Kentaro, et al.
Publicado: (2020)

Patient Alerting Features in Implantable Defibrillators
por: Vollmann, Dirk, et al.
Publicado: (2008)

Remote Monitoring of Implantable Cardioverter Defibrillator
por: Reynolds, Dwight W, et al.
Publicado: (2006)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
por: Nair, Krishnakumar, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_bati0vkjnu9evreamra2fqot85